KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo
Year: 2008
Type: article
Source: Molecular Cancer Therapeutics
Authors: Christian A. Hassig, Kent T. Symons, Xin Guo, Phan-Manh Nguyen, Tami Annable, Paul L. Wash, Joseph E. Payne, David A. Jenkins, Céline Bonnefous, Carol Trotter, Yan Wang, John V. Anzola, Elena L. Milkova, Timothy Z. Hoffman, Sara J. Dozier, Brandon M. Wiley, Alan Saven, James W. Malecha, Robert L. Davis, Jerry Muhammad, Andrew K. Shiau, Stewart A. Noble, Tadimeti S. Rao, Nicholas D. Smith, Jeffrey H. Hager
Institutions: Scripps Green Hospital, Scripps Clinic
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2103486077